Results

Total Results: 6,952 records

Showing results for "weeks".

3301. 75Ftpgw4Rz-3Tdmqpstvdg (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/75ftPGW4rZ-3tdMQPstvDg
      August 01, 2012 - The number needed to treat with exercise or physical therapy for a median of approximately 12 weeks to

3302. Autism-Update Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/autism-update_executive.pdf
      August 01, 2014 - intensity, with most interventions consisting of 1–2 hour sessions/week lasting approximately 4–5 weeks … However, some of the group-based approaches lasted 15–16 weeks. … based, and combinations), intensity (12 hours over 3 months vs. 30 hours over 1 week), and duration (weeks … from 18 months to 7 years); and many different outcome measurements over different periods of time (weeks

3303. Antipsychotics-Adults Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-adults_executive.pdf
      August 01, 2012 - The length of followup ranged from <1 day to 22 years (median = 8 weeks [IQR, 6 to 26 weeks]). … AEs due to the relatively short followup of the included studies: study followup periods averaged 8 weeks

3304. Diagnosis and Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-fatigue_executive.pdf
      July 01, 2016 - Randomized controlled trials of at least 12 weeks in duration that compared medications, complementary … Additional trials with durations less than 12 weeks indicated no differences between placebo and acyclovir59 … †Trial less than 12 weeks in duration Seven trials compared complementary and alternative medicine

3305. S149 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/s149.pdf
      October 01, 2007 - Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with … Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients … Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated

3306. untitled (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/VNs-WaxpPcsodxCb57gYmn
      January 03, 2017 - effect of treatment with CPAP on mor- tality; most trials (29/31) followed up participants for only 12 weeks … Follow-up in these studies was generally from 8 to 12 weeks, and most participants were men, with a mean … Follow-up in these studies was generally from 4 to 6 weeks.

3307. CHIPRA Pediatric Quality Measures Program (PQMP) Candidate Measure Submission Form (CPCF) (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/outcomes/chipra-140-section-5.8.pdf
      January 01, 2014 - analysis of interview data to explore how parents at risk of delivering very premature infants (22 to 25 weeks … A validated single-item measure was used to assess adherence to HAART over the prior 4 weeks. … All of the patients had reported pain levels ≥4 on a scale of 0 to 10 or pain in the past 2 weeks which

3308. Archived: Lipid Disorders in Children and Adolescents: Screening | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/recommendation/lipid-disorders-in-children-screening-july-2016
      August 09, 2016 - Trial duration ranged from 6 weeks to 2 years, with most lasting less than 1 year. … supplementation (30 g/d) in children aged 8 to 18 years with moderate to severe dyslipidemia found no effect at 4 weeks … Trial duration ranged from 8 weeks to 2 years. 1 Bile acid-sequestering agents were commonly associated

3309. Screening for Depression in Adults: USPSTF Final Recommendation Statement (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/BnHj53HwgSBNXMvnyavxfS
      January 26, 2016 - 46% remission rate with antidepressants and a 48% remission rate with psycho- therapy after 10 to 16 weeks … geographic location (United States, northern Europe, United Kingdom, and Hong Kong), length of follow-up (11 weeks … Fifteen trials were in postpartum women (usually 6-12 weeks postpartum) and 3 trials were in pregnant

3310. Final Progress Report: The Impact of Shift-Accumulated Fatigue on Patient Care and Risk of Post-Shift Driving Collisions among 12-Hour Day and Night Shift Nurses (pdf file)
      www.ahrq.gov/sites/default/files/2024-10/james-report.pdf
      January 01, 2024 - condition first, or “rest” condition first and were scheduled for testing days (with at least 4 weeks

3311. Alcohol-Misuse Research-Protocol (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse_research-protocol.pdf
      April 28, 2010 - updated after draft report goes out for peer review Length of followup At least 6 months (24 weeks

3312. Real-time Assessment of Dialogue in Motivational Interviewing (ReadMI) - Final Report (pdf file)
      digital.ahrq.gov/sites/default/files/docs/citation/r21hs026548-hershberger-final-report-2022.pdf
      January 01, 2022 - Real-time Assessment of Dialogue in Motivational Interviewing (ReadMI) - Final Report Real-time Assessment of Dialogue in Motivational Interviewing (ReadMI) Paul J. Hershberger, Ph.D. – Prin…

3313. Final Progress Report: Evaluation of Risk by Active Surveillance in the Emergency Department (ERASED) (pdf file)
      www.ahrq.gov/sites/default/files/2024-01/hall1-report.pdf
      January 01, 2024 - Final Progress Report: Evaluation of Risk by Active Surveillance in the Emergency Department (ERASED) Principal Investigator: Hall, Kendall K. 7P20HS017111-02 FINAL REPORT Evaluation of Risk by Active Surveillance in the Emergency Department (ERASED) Principal Investigator: Kendall K. Hall, MD, MS (University of …

3314. Studies in Meta-analyses (continued, 3) | Agency for Healthcare Research and Quality
      www.ahrq.gov/prevention/guidelines/tobacco/clinicians/references/meta/meta03.html
      December 01, 2012 - Controlled trial of three weeks nicotine replacement treatment in hospital patients also given advice

3315. Zyao53-Sqrb6Ozzkzdmjjt (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/ZYao53-sqRb6oZzKzDmjjt
      December 01, 2003 - systematic review found that sibutramine promoted 2.8 to 4.2 kg of weight loss (7 RCTs) over 8 to 52 weeks

3316. Evidence Report on the (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/measuring-blood-pressure_research-protocol.pdf
      April 11, 2011 -  Duration of followup: ≥8 weeks.  No minimum sample size. … Prospective longitudinal study  N ≥ 100 for adults; N ≥ 10 for children  Duration of followup: ≥8 weeks

3317. AHRQ National Web Conference on Applying Advanced Analytics in Clinical Care - Q&As (pdf file)
      digital.ahrq.gov/sites/default/files/docs/clinical-care-qas-10142020.pdf
      October 14, 2020 - time it takes to adapt natural language processing tools to a new source of data can range from a few weeks … time it takes to adapt natural language processing tools to a new source of data can range from a few weeks

3318. Evidence Report on the (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/glaucoma-screening_research-protocol.pdf
      November 16, 2010 - If no response is received within 6 weeks, we will assess the study based upon the available data provided … case of failure to communicate with the primary investigators, or if there is no response within 6 weeks

3319. Glaucoma-Treatment Research-Protocol (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/glaucoma-treatment_research-protocol.pdf
      November 16, 2010 - If no response is received within 6 weeks, we will assess the study based upon the available data provided … case of failure to communicate with the primary investigators, or if there is no response within 6 weeks

3320. Microsoft PowerPoint - Updated Handouts - Read-Only (pdf file)
      cds.ahrq.gov/sites/default/files/cds/artifact/136331/Opioid%20Patient%20Handout.pdf
      July 18, 2023 - . • A common goal is to lower the dose of opioids by 10%-20% every 1-4 weeks or months.